PacificGMP Increases Production Capacity

Published on: 

PacificGMP doubles its GMP production capacity with the addition of a second System 1000 Bioreactor platform.

PacificGMP, a CMO, has doubled its GMP production capacity with the addition of a second System 1000 Bioreactor platform from GE Healthcare. This second System 1000, with a 500 L working volume, increases PacificGMP’s large scale GMP production capacity to 1000 L for fed and fed-batch production. In addition, it provides an additional 15,000 L of production capacity when run in perfusion mode. The addition provides PacificGMP a total perfusion capacity of 30,000 L.

Expansion of its operational capacity will allow PacificGMP to increase its large scale clinical manufacturing projects for its research clients, customers, and partners.

Advertisement

Source: PacificGMP